Copyright
©The Author(s) 2017.
World J Gastrointest Oncol. Sep 15, 2017; 9(9): 390-396
Published online Sep 15, 2017. doi: 10.4251/wjgo.v9.i9.390
Published online Sep 15, 2017. doi: 10.4251/wjgo.v9.i9.390
Figure 5 Immunohistochemical study in the surgical specimen.
A: CK5/6 strong positivity in squamous component (metaplasia and carcinoma), × 20; B: Strong nuclear p63 immunopositivity in the invasive squamous carcinoma. The adenocarcinoma area display poor p63 nuclear positivity, × 20; C: MUC5a negativity in the squamous carcinoma component and strong positive in ductal epithelial cells, × 20; D: MUC1/EMA positivity in the squamous metaplasic component, × 20.
- Citation: Martínez de Juan F, Reolid Escribano M, Martínez Lapiedra C, Maia de Alcantara F, Caballero Soto M, Calatrava Fons A, Machado I. Pancreatic adenosquamous carcinoma and intraductal papillary mucinous neoplasm in a CDKN2A germline mutation carrier. World J Gastrointest Oncol 2017; 9(9): 390-396
- URL: https://www.wjgnet.com/1948-5204/full/v9/i9/390.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v9.i9.390